In patients with AE-IPF, the expression of cyclin A2 and α-defensin is upregulated, whereas advanced glycation end-product receptor levels are reduced, leading to marked alveolar epithelial injury and apoptosis (Konishi et al., 2009). The gene discussed is AGER; the disease is idiopathic pulmonary fibrosis.